HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

Profit from the Pros – Zacks Free Email Newsletter
Our free email newsletter is filled with timely stock picks and market commentary. Sign up for free. Already on board? Check out the archive.
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive


BLUD: Immucor Inc - Full Company Report Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Full Company Report |  Estimates |  Brokerage Recommendations |  Comparison to Industry |  Insiders |  Brokerage Reports |  Zacks Equity Research   |  Annual Report
IMMUCOR INC (NASD)
BLUD 18.77 -0.03 (-0.16%) Vol.  431,341 16:00 ET
Immucor is an international in vitro diagnostic company dedicated to automating manual processes in the hospital/donor laboratory. They develop, manufacture, and sell products used by hospital blood banks, clinical laboratories, and large blood-donor centers to test, detect, and identify certain properties of human blood prior to patient transfusion. Immucor's instruments utilize patented solid phase technology reagents to perform ABO grouping tests, RH typing, antibody screening, and platelet cross-matching.

 General Information
IMMUCOR
3130 Gateway Drive
P.O. Box 5625
Norcross, GA 30091-5625
Phone: 770 441-2051
Fax: 770 441-3807
Web: www.immucor.com
Email: info@immucor.com
 
Industry MED/DENTAL-SUPP
Sector: Medical
 
Fiscal Year End May
Last Reported Quarter 08/31/09
Next EPS Date 01/06/2010
 
 Price and Volume Information
Zacks Rank
Yesterday's Close 18.80
52 Week High 29.20
52 Week Low 11.24
Beta 0.74
20 Day Moving Average 607,667.94
Target Price Consensus 19.63
 
 % Price Change
4 Week 4.10
12 Week 2.74
YTD -29.38
 % Price Change Relative to S&P 500
4 Week 2.98
12 Week -3.14
YTD -41.56
 Share Information
Shares Outstanding (millions) 70.14
Market Capitalization (millions) 1,316.45
Short Ratio 3.20
Last Split Date 05/16/2006
 Dividend Information
Dividend Yield 0.00%
Annual Dividend $0.00
Payout Ratio 0.00
Change in Payout Ratio 0.00
Last Dividend Payout / Amount NA / $0.00

 EPS Information
Current Quarter EPS Consensus Estimate 0.26
Current Year EPS Consensus Estimate 1.15
Estimated Long-Term EPS Growth Rate 15.70
Next EPS Report Date 01/06/2010
 Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell) 2.50
30 Days Ago 2.50
60 Days Ago 2.20
90 Days Ago 2.20

 Fundamental Ratios
 P/E
Current FY Estimate: 16.27
Trailing 12 Months: 17.06
PEG Ratio 1.04
 EPS Growth
vs. Previous Year 7.14%
vs. Previous Quarter 3.45%
 Sales Growth
vs. Previous Year 13.52%
vs. Previous Quarter: 5.10%
 Price Ratios
Price/Book 3.29
Price/Cash Flow 14.55
Price / Sales 4.24
 ROE
08/31/09 21.34
05/31/09 22.07
02/28/09 22.58
 ROA
08/31/09 18.18
05/31/09 18.69
02/28/09 19.07
 Current Ratio
08/31/09 4.60
05/31/09 4.68
02/28/09 4.85
 Quick Ratio
08/31/09 3.88
05/31/09 3.95
02/28/09 4.04
 Operating Margin
08/31/09 25.44
05/31/09 25.82
02/28/09 25.86
 Net Margin
08/31/09 38.54
05/31/09 38.92
02/28/09 40.06
 Pre-Tax Margin
08/31/09 38.54
05/31/09 38.92
02/28/09 40.06
 Book Value
08/31/09 5.71
05/31/09 5.46
02/28/09 5.08
 Inventory Turnover
08/31/09 2.35
05/31/09 2.38
02/28/09 2.35
 Debt-to-Equity
08/31/09 0.00
05/31/09 0.00
02/28/09 0.00
 Debt to Capital
08/31/09 0.00
05/31/09 0.00
02/28/09 0.00

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research